Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Diabetes Drug Adherence: Injectables vs. Oral Medication

By Meg Snyder | October 27, 2016

In adults, types 2 diabetes accounts for 90-95 percent of diagnosed cases of diabetes. In the U.S., 29.1 million people are estimated to have diabetes, with an approximate 8.1 million people who aren’t aware of their condition. 

To manage their diabetes, the CDC reports that 50.3 percent of patients take pills only, 17.8 take insulin only, and 13 percent take both pills and insulin. But how many of those patients, regardless of the medication they are prescribed, are actually adhering to their prescribed dosages? 

Medisafe, a personalized medication management platform addressing non-adherence causes, created an infographic—revealing statistics related to diabetes drug adherence. 

The statistics that I found the most interesting are as follows:

  • 3 pm and 9 pm had the lowest levels of patient medication adherence
  • People like to take the day off on Saturday—including from their pills (with a 72 percent medication adherence—compared to 78 percent on Monday)
  • There was a slightly higher level of adherence for vials/syringes prescribed 1-2 times per day (as compared to the pen)—77 vs. 71 percent
  • There was little difference in adherence to injectables vs. oral medication (76 vs. 74 percent)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!  


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE